China Securities Regulatory Commission: By 2025, our macro policy orientation will be more proactive and effective, with unexpectedly increased counter-cyclical regulation intensity.

On January 13, the China Securities Regulatory Commission held a system work meeting for 2025, summarizing the work of 2024, advancing the inspection rectification thoroughly, and studying the key tasks for 2025. Wu Qing, the Secretary of the Party Committee and Chairman of the China Securities Regulatory Commission, attended the meeting and spoke. The meeting noted that in 2024, the securities regulatory system would adhere to the guidance of ****'s thought on socialism with Chinese characteristics for a new era, thoroughly implement the decision-making and deployment of the Party Central Committee and the State Council, coordinate risk prevention, strengthen regulations, promote high-quality development, reinforce the foundation, exercise strict oversight and management, leading to positive and profound changes in the capital markets. Firstly, promote the introduction of new "National Nine Articles" for the capital markets and "

China Securities Regulatory Commission1minutes ago

Here's What Trump's Economic Team Is Saying About Tariffs

Seeking Alpha27minutes ago

Asia And Europe Markets Fall, Dollar Hits New High - Global Markets Today While US Slept

Benzinga41minutes ago

The Growth Tech stocks in the U.S. market are experiencing a Top Reversal, how to use Options to seize good entry opportunities?

On one hand, if entering the market too quickly, stock prices may fall unexpectedly, potentially resulting in significant losses; on the other hand, if the "bottom guessing" fails, missing the best timing for positioning may lead to missing the desired price for the stocks. In this situation, the flexible use of several options strategies may help the trade align more with market trends.

Futu News54minutes ago

U.S. Stock Market Insights | Delta Air Lines has scored big! Stock prices hit a new high, with performance and outlook both exceeding expectations; a $16.4 billion acquisition of Calpine, Energy giant CEG surged by 25.16%.

The Medical merger and acquisition frenzy has started again! It is rumored that Johnson & Johnson is in talks to acquire the biopharmaceutical company Intra-Cellular Therapies Inc., which focuses on treating central nervous system diseases, and its stock price has soared nearly 15%.

Futu News18:31

Daily Options Tracking | The high-performing stock WBA surged nearly 30% last Friday, with a call option expiring this Friday netting over 5 times profit; Tesla's Put ratio rose to 45%, with large investors spending tens of millions of dollars on bullish

NVIDIA fell over 3% in the previous trading day, with the Options Chain volume increasing to 4.15 million contracts, of which Put options accounted for 40.8%; on the Options Chain, the call option with a strike price of 140 dollars expiring this Friday had the highest volume of 0.236 million contracts, with an open interest of 0.251 million contracts.

Futu News17:56